Menu
Get in Touch
info@emkomnipharma.com

A unit of Sri Rama Associates

Metomni-XL-25 - Angle 1
Angle 1 of 3

Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

Blood Pressure Management

Metomni-XL-25

Composition

Metoprolol Succinate IP 25 mg, along with approved excipients

Dosage Strength

25 mg

Medicine Type

Tablet

Pack Size

10 X 10 Tablets

Storage Instructions

Metomni-XL 25 Metoprolol Succinate ER Tablets IP should be stored in a cool, dry, and dark place, protected from direct sunlight.

Caution

The medicine must be kept out of reach of children.

Product Information

Metomni-XL 25 by EMK Omni Pharma is a prescription-based Metoprolol Succinate ER Tablets IP formulation used for doctor-supervised blood pressure management, heart rate control, and cardiovascular health support. Each uncoated extended release tablet contains Metoprolol Succinate IP 25 mg. Metomni-XL 25 belongs to the beta-blocker category of medicines and is commonly prescribed by healthcare professionals for patients who require support in managing hypertension, high blood pressure, elevated heart rate, cardiac workload, and long-term heart health. Metomni-XL 25 Metoprolol Succinate Extended Release Tablets by EMK Omni Pharma are designed for physician-guided cardiac care where sustained release support, blood pressure control, heart rate regulation, and cardiovascular risk management are required. This medicine should be used only as advised by a registered medical practitioner. Metomni-XL 25 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, elevated heart rate, cardiac strain, and cardiovascular risk factors. It may be used as part of a complete physician-guided heart care plan for individuals who need blood pressure management, heart rate regulation, and long-term cardiac health support. Metomni-XL 25 by EMK Omni Pharma is suitable for doctor-supervised treatment where sustained blood pressure control, cardiac workload reduction, heart rate management, and cardiovascular support are required. Patients should not self-medicate, change the dosage, stop the medicine suddenly, chew or crush the tablet, or combine it with other medicines without consulting their doctor.

Medical Disclaimer

This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.